logo
logo
FutureFuel Corp.

FutureFuel Corp.

NYSE•FF
CEO: Mr. Paul Anthony Novelly
セクター: Basic Materials
業種: Chemicals
上場日: 2011-03-23
FutureFuel Corp., together with its subsidiaries, manufactures and sells diversified chemical, bio-based fuel, and bio-based specialty chemical products in the United States. The company operates through two segments, Chemicals and Biofuels. The Chemicals segment provides various custom chemicals that are used in the coatings, chemical intermediates, industrial and consumer cleaning, oil and gas, and specialty polymers industries; and performance chemicals, such as polymer modifiers, glycerin products, and various specialty chemicals and solvents. The Biofuels segment is involved in the production and sale of biodiesel and petrodiesel blends; and markets its biodiesel products directly to customers through trucks, barges, and rail cars. FutureFuel Corp. is headquartered in Saint Louis, Missouri.
連絡先情報
8235 Forsyth Boulevard, Suite 400, Saint Louis, MO, 63105, United States
314-854-8352
futurefuelcorporation.com
時価総額
$164.70M
PER (TTM)
-4.8
0.7
配当利回り
6.4%
52週高値
$5.01
52週安値
$3.09
52週レンジ
35%
順位34Top 27.8%
4.7
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
堅調 • 4.7 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q3 2025 データ

売上高

$22.69M-55.63%
直近4四半期の推移

EPS

-$0.21+669.23%
直近4四半期の推移

フリーCF

-$6.46M-131.52%
直近4四半期の推移

2025 Q3 決算ハイライト

主なハイライト

Revenue Plummets 58% Revenue $75.9M, down 58% for nine months, reflecting biofuel segment uncertainty and production line idling.
Operations Deep Loss Operating loss reached $(40.5M) for nine months, a major reversal from prior year income of $4.8M.
Cash Flow Reverses Operating cash flow shifted to $(1.3M) used over nine months, compared to $41.4M provided last year.
Equity Declines Significantly Total equity declined to $169.1M from $205.8M due to significant net losses incurred year-to-date.

リスク要因

Biofuel Production Halted Biofuel segment revenue dropped 79% quarterly due to temporary idling of production line amid CFPC uncertainty.
Chemical Segment Loss Worsens Chemical segment gross loss worsened to $(8.5M) for nine months due to plant turnaround costs and lower volumes.
Negative EPS Trend Basic EPS $(0.85) for nine months, a substantial negative shift from $0.29 earnings per share last year.
Derivative Volatility Impact Derivative instrument gains/losses caused net income volatility, recording $(404K) unrealized loss in 9M 2025.

見通し

Awaiting CFPC Regulatory Clarity Awaiting EPA final rule on CFPC, which could materially affect future competitive environment for biodiesel.
Sufficient Liquidity Maintained Management believes current cash and $75M credit facility sufficient for foreseeable operations and capital needs.
Tax Credit Benefits Recognized Recognized $2.5M in CFPC for nine months; expecting continued benefit from this key low-emission fuel incentive.
Credit Facility Unused No borrowings utilized under the amended $75M Credit Facility as of September 30, 2025 reporting date.

同業比較

売上高 (TTM)

Mercer International Inc.MERC
$1.87B
-8.6%
Lavoro LimitedLVRO
$1.75B
-3.7%
Friedman Industries, IncorporatedFRD
$584.35M
+30.5%

粗利益率 (最新四半期)

BioHarvest Sciences Inc. Common StockBHST
61.4%
+4.6pp
TRX Gold CorporationTRX
56.4%
+18.2pp
American Vanguard CorporationAVD
28.7%
+14.1pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
TRX$496.44M-109.3-7.6%3.5%
SMID$176.70M15.025.0%5.5%
FF$164.70M-4.8-18.7%0.0%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-28.3%
成長鈍化
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
25%
キャッシュフローに注意が必要

深度リサーチ

次回決算:2026年3月26日
|
EPS:-
|
売上高:-
財務レポート
財務データ
全年度
  • Form 10-Q - Q3 2025

    会計期末: 2025年9月30日|提出日: 2025年11月10日|
    売上高: $22.69M-55.6%
    |
    EPS: $-0.21+669.2%
    不明
  • Form 10-Q - Q2 2025

    会計期末: 2025年6月30日|提出日: 2025年8月11日|
    売上高: $35.67M-50.7%
    |
    EPS: $-0.24-209.1%
    不明
  • Form 10-Q - Q1 2025

    会計期末: 2025年3月31日|提出日: 2025年5月12日|
    売上高: $17.54M-69.9%
    |
    EPS: $-0.40-504.4%
    不明
  • Form 10-K - FY 2024

    会計期末: 2024年12月31日|提出日: 2025年3月31日|
    売上高: $243.34M-33.9%
    |
    EPS: $0.35-58.8%
    不明
  • Form 10-Q - Q3 2024

    会計期末: 2024年9月30日|提出日: 2024年11月8日|
    売上高: $51.14M-56.2%
    |
    EPS: $-0.03-145.5%
    予想を下回る
  • Form 10-Q - Q2 2024

    会計期末: 2024年6月30日|提出日: 2024年8月9日|
    売上高: $72.41M-15.1%
    |
    EPS: $0.22-195.7%
    予想を下回る
  • Form 10-Q/A - Q3 2023

    会計期末: 2023年9月30日|提出日: 2024年5月10日|
    売上高: $116.75M-1.2%
    |
    EPS: $0.06-83.3%
    不明
  • Form 10-Q/A - Q2 2023

    会計期末: 2023年6月30日|提出日: 2024年5月10日|
    売上高: $85.31M-27.6%
    |
    EPS: $-0.23+224.4%
    不明